Skip to main content
Braster S.A. logo

Braster S.A. — Investor Relations & Filings

Ticker · BRA ISIN · PLBRSTR00014 LEI · 259400GV3T3LOS094487 WAR Manufacturing
Open in API
Filings indexed 1,512 across all filing types
Latest filing 2024-01-31 Report Publication Anno…
Country PL Poland
Listing WAR BRA

About Braster S.A.

https://www.braster.eu/en

Braster S.A. is a medical technology company specializing in the development, production, and marketing of diagnostic devices for breast health. Its core product is the Braster System, a medical device designed for regular, in-home breast examination. The system utilizes a proprietary contact thermography method with liquid crystal technology to monitor temperature distribution within the breasts. It functions by detecting and recording areas of elevated temperature, which may indicate pathological changes. The Braster device is intended as a non-invasive, complementary screening tool to be used by women as an adjunct to standard diagnostic procedures such as mammography and ultrasound, promoting systematic breast health monitoring.

Recent filings

Filing Released Lang Actions
Terminy publikacji raportów okresowych Spółki w 2024 roku - Content (PL)
Report Publication Announcement Classification · 100% confidence The document text, written in Polish, explicitly states that the Management Board of Braster S.A. is announcing the schedule ('terminy') for releasing periodic reports ('raportów okresowych') for the year 2024, including the annual report, Q1, H1, and Q3 reports. This is not the report itself, but an announcement about when the reports will be published. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2024-01-31 Polish
Zawarcie porozumienia dotyczącego dystrybucji i sprzedaży urządzeń medycznych Spółki w Turcji, Azerbejdżanie oraz krajach Azji Środkowej - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement written in Polish by the Management Board ('Zarząd') of Braster S.A. It details the signing of a Memorandum of Understanding (MOU) with a distributor for the distribution and sale of medical devices in Turkey and Central Asian countries. The content focuses on a potential business agreement, exclusivity terms contingent on sales targets, and future steps (negotiating a final agreement). This type of announcement, concerning strategic business cooperation or potential transactions that are not yet finalized M&A deals, typically falls under general regulatory announcements or significant business updates. Since it is not a standard financial report (10-K, IR, ER), a management change (MANG), or a director's dealing (DIRS), and it describes a significant business development, it best fits the 'Regulatory Filings' (RNS) category as a general regulatory announcement, or potentially 'TAR' if it were a definitive agreement, but since it's an MOU, RNS is more appropriate as a catch-all for significant, non-standard disclosures. Given the short length and the nature of disclosing a strategic partnership agreement (MOU), RNS is the most suitable classification.
2024-01-19 Polish
Otrzymanie zawiadomień o wszczęciu egzekucji z majątku emitenta na wniosek wierzyciela - Content (PL)
Legal Proceedings Report Classification · 98% confidence The document text is a formal notification from the Management Board ('Zarząd') of Braster S.A. detailing the initiation of enforcement proceedings ('egzekucji') by a Court Enforcement Officer ('Komornik Sądowy') against the company based on civil procedure code articles (k.p.c.). This concerns legal action, specifically debt collection and seizure of assets (movable and immovable property). This directly relates to significant lawsuits or regulatory actions involving the company. Therefore, the most appropriate classification is Legal Proceedings Report (LTR). The document is a direct report of the event, not an announcement of a report.
2024-01-16 Polish
Przedłużenie terminu realizacji projektu pn. "System komputerowej interpretacji i wspomagania diagnostyki onkologicznej gruczołu piersiowego działający w oparciu o techniki głębokiego uczenia, w s...
Capital/Financing Update Classification · 95% confidence The document is a short announcement (1235 characters) written in Polish. It references previous periodic reports (Q3 2023) and discusses an amendment (aneks) made to a co-financing agreement with the National Centre for Research and Development (NCBR) regarding a specific project. The amendment extends the project completion deadline and confirms the total cost and remaining grant amount. This type of announcement, detailing changes to financing terms or project status related to grants/funding, fits best under 'Capital/Financing Update' (CAP) or potentially a general 'Regulatory Filing' (RNS). Since it specifically details a change in the terms of a significant funding agreement (grant extension), CAP is the most precise fit, as it relates to capital structure/financing activities, even if it's grant-based.
2024-01-10 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zgromadzeniu rozpoczętym dniu 20 grudnia 2023 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document text is in Polish and discusses the results of a shareholder vote during an 'Zwyczajnym Walnym Zgromadzeniu Spółki' (Ordinary General Meeting). It explicitly details the number of votes held by a specific shareholder ('Pani Małgorzata Krzyżanowska') before and after a recess during the meeting. This content directly corresponds to the declaration of voting results from a general meeting. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is very short (702 chars), but since it contains the actual results rather than announcing the publication of results, DVA is more specific than RPA or RNS.
2023-12-27 Polish
Podpisanie umowy współpracy w zakresie dystrybucji i sprzedaży urządzeń medycznych Spółki w Stanach Zjednoczonych, Kanadzie i na Karaibach - Content (PL)
Regulatory Filings Classification · 94% confidence The document text, written in Polish, describes the signing of an 'Exclusive Distribution agreement' (Umowa) between Braster S.A. (the Issuer) and A Unity Systems Inc. (the Distributor) for the exclusive distribution of medical devices in the USA, Canada, and the Caribbean. It details the scope, sales targets (projected revenue of $3.65 million USD in the first year post-FDA registration), and the 3-year term of the agreement. This content relates to a significant business transaction, partnership, or contract signing that impacts the company's operations and potential revenue, but it does not fit neatly into standard financial reports (10-K, IR, ER) or specific corporate actions like dividends, director dealings, or capital changes. Since it is a report about a significant commercial agreement (a form of strategic transaction), and given the available codes, it is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of a material event, or potentially a general business update that doesn't map perfectly. Given the nature of disclosing a material contract, RNS is the most appropriate fallback category for significant, non-standard disclosures.
2023-12-27 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.